Heron Therapeutics
HRTX
HRTX
176 hedge funds and large institutions have $2.37B invested in Heron Therapeutics in 2018 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 69 increasing their positions, 60 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
9% less funds holding
Funds holding: 194 → 176 (-18)
14% less capital invested
Capital invested by funds: $2.77B → $2.37B (-$401M)
44% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 41
Holders
176
Holding in Top 10
9
Calls
$7.3M
Puts
$3.97M
Top Buyers
| 1 | +$66.5M | |
| 2 | +$22.3M | |
| 3 | +$21.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$19.6M |
| 5 |
NC
Nexthera Capital
New York
|
+$18.9M |
Top Sellers
| 1 | -$40.3M | |
| 2 | -$21.1M | |
| 3 | -$20.6M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$17.9M |
| 5 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$10.3M |